Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chronimed to spin off diagnostics business:

This article was originally published in Clinica

Executive Summary

Chronimed, a US patient management and supply service for people with chronic conditions, is to spin off its diagnostic products division into a separate company that will trade on the Nasdaq stock exchange. Minneapolis, Minnesota-based Chronimed will distribute shares as a tax-free dividend to shareholders. The decision comes after consultancy led by Paine-Webber identified the separate nature of the company's pharmacy and diagnostics businesses.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel